Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
AI technology can be used to detect potentially deadly blood clots before they hit.
This is to scientists at the University of Tokyo, who say they have created a non -invasive way of observing the blood clotting activity.
New artificial intelligence The tool uses a powerful microscope for real -time thrombocytes, and researchers are divided into a statement for a public at the University.
What is artificial intelligence (AI)?
Thrombocytes, which are small blood cells that help form clots to stop bleeding, play “a key role” in heart disease, especially Coronary artery diseaseAccording to Dr. Kazutoshi Hirose, the leading author of the study.
If the number of thrombocytes is too high, it may increase the risk of blood clots.
Scientists at the University of Tokyo have discovered a non -invasive way of observing the blood clotting activity as it happens. (East)
To prevent dangerous clots, patients with coronary disease are usually treated with thrombocyte drugs.
“However, it is still challenging to assess accurately how well these drugs work in each individual, which is the monitoring of thrombocytes activities to the goal of both doctors and for researchers,” Hirose said in a statement to the public.
How the tool works
Traditional methods of tracking activity of thrombocytes often rely on indirect measurements or invasive procedures.
In addition to the AI tool, a large drive microscope acts like a “super-large camera that captures sharp pictures of blood cells in the flow,” said Yuqi Zhou, Assistant Professor of Chemistry at the University of Tokyo, in edition.
Artificial intelligence transforms patients’ care and reduces combustion, says the doctor
“As traffic cameras shoot every car on the road, our microscope captures thousands of pictures bloodstream On the move every second, “he said.” We then use artificial intelligence to analyze these images. “
AI can distinguish one thrombocyte (“like one car”), a thrombocyte accumulation (“like traffic jam”), or even marking white blood cells (“like a police car caught in jam”), Zhou described.
“Right now, doctors often give drugs with blood dilution and hope to work. With this method, they could actually see if he was doing treatment.”
“This technology stands out because it allows doctors to directly observe the thrombocies in the bloodstream and measures how to communicate and form lumps in real time,” said Keisuke Goda, a professor at the University of Tokyo Chemistry Department.
“Our studies have shown that it is very effective in patients with Coronary artery diseaseThe most common cause of heart attacks and one of the leading causes of death in the USA to the world, “he added.
Traditional methods of tracking activity of thrombocytes often rely on indirect measurements or invasive procedures, according to researchers. (East)
When researchers tested technique to over 200 patients, they found that people with more serious heart problems were more gathered in their blood.
Blood sample Taking off the patient’s hand and tested with a tool resulted in almost the same results as blood taken directly from the cardiac arteries, they noticed.
Implications of treatment
Harvey Castro, an emergency -based emergency doctor and an emergency expert, described implications as significant for patients’ care.
“Today we rely on indirect laboratory markers or invasive blood blood to judge the risk of clots,” said Castro, who was not involved in the studio, for Fox News Digital.
Click here to get the Fox News app
“This technology The ordinary venous draw converts into a living telemetry of thrombocyte behavior, giving answers in a second, not for hours. “
These progress can potentially change the standard of care for patients with coronary heart disease, according to researchers.
Click here to sign up for our Health Bulletin
“Usually, if doctors want to understand what is happening in the arteries, especially coronary arteries, they should do invasive procedures, such as inserting a catheter through the joint or groin to collect blood,” Hirose said.
In a tool efficiency studies, a regular blood test showed almost the same results as blood taken directly from the cardiac arteries. (East)
“What we have discovered is that only taking a regular blood sample from the vein in the hand can still provide significant information on the activities of thrombocytes in the arteries.”
For more health articles visit www.foxnews.com/health/health
Goda agreed that the tool could enable safer, more Personalized treatments For patients with heart disease diseases.
“Right now, doctors often give drugs with blood dilution and hope to work,” he said. “With this method, you could actually see if treatment for each patient is doing.”
Potential limitations
Castro warned that technology He is not ready for wide use yet.
“The microscope is top -notch research equipment, and it’s not yet a bed bed,” he told Fox News Digital. “We need miniaterization and a drop in costs before each ER can use it.”
“What we have discovered is that only taking a regular blood sample from the vein in the hand can still provide significant information on the activities of thrombocytes in the arteries.” (East)
Looking in advance, after further research, Castro predicts that this innovation could change the decision -making for patients.
“In five years, I can imagine an analyzer for a care that allows me to adjust the anti -guild medication and how I quickly and safely titrate the oxygen for the patient in front of me,” he said.
